Two new 16-week tuberculosis regimens advance in clinical trial

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Tuberculosis remains one of the world's deadliest infectious diseases, causing more than 1 million deaths each year. The development of new therapeutic regimens remains slow, costly and complex, while treatment remains lengthy and patients face the burden of side effects. Accelerating the identification of safer, shorter and more effective treatment options is essential to achieving global TB…

Read original article on Medical Xpress - latest medical and health news stories →